home / stock / skye / skye news

SKYE News and Press, Skye Bioscience Inc Com

Stock Information
Company Name: Skye Bioscience Inc Com
Stock Symbol: SKYE
Market: OTC
Website: skyebioscience.com
Menu
SKYE SKYE Quote SKYE Short SKYE News SKYE Articles SKYE Message Board
Get SKYE Alerts

News, Short Squeeze, Breakout and More Instantly...
SKYE - US Companies Moving the Markets, Evening edition
Fri, Jul 05, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 38.2% to $0.24 on volume of 498,894,705 shares Qualigen Therapeutics Inc. (QLGN) rose 59.5% to $0.28 on volume of 243,116,946 shares NVIDIA Corporation (NVDA) fell 1.9% to $125.83 on volume o...
SKYE - Skye Bioscience Appoints Dr. Karen Smith to Board of Directors

SAN DIEGO, July 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye" or the "Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system...

SKYE - Google DeepMind CEO: 'This Is the Next $100 Billion AI Business'

2024-07-01 11:13:20 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Editor’s note: “Google DeepMind CEO: ‘This Is the Next $100 Billion AI Business’ “ was previously published in May 2024. It has since been updated...

SKYE - Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes

SAN DIEGO, July 01, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announ...
SKYE - Skye BioScience Participating in Piper Sandler Virtual Obesity Day

SAN DIEGO, June 25, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) ("Skye" or the "Company”), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system...

SKYE - Skye Bioscience pulls plug on glaucoma drug, stock tumbles 15%

2024-06-10 13:52:55 ET More on Skye Bioscience Skye Bioscience to uplist to Nasdaq Global Market Seeking Alpha’s Quant Rating on Skye Bioscience Historical earnings data for Skye Bioscience Financial information for Skye Bioscience Read the f...

SKYE - Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program

SBI-100 Ophthalmic Emulsion Phase 2a trial does not achieve target product profile; program discontinued Phase 2 study of Nimacimab in obesity expected to start in Q3 2024 Cash runway extended into 2027 SAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience...
SKYE - Skye Bioscience to Present at Jefferies Global Healthcare Conference

SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announ...

SKYE - Russell Microcap: Virgin Galactic, Skye Bioscience among industrial additions, Workhorse, Sterling Infrastructure among deletions

2024-05-30 14:07:56 ET More on Dollar General, IZEA Worldwide, etc. Dollar General Corporation (DG) Q1 2024 Earnings Call Transcript Modine Manufacturing: AI Growth Stock Surged More Than 250% In One Year SentinelOne Q1 Earnings Preview: Growth Momentum, Despite Peer...

SKYE - Russell 3000: Tecnoglass, Skye Bioscience among industrial additions; Nikola, Workhorse among deletions

2024-05-30 13:35:28 ET More on CRH, Microvast Holdings, etc. Workhorse Group Inc. (WKHS) Q1 2024 Earnings Call Transcript CRH Is Poised To Benefit From A Major Growth Cycle Pagaya: Patience Should Pay Off Nikola discloses order of 100 hydrogen fuel cell truck...
Next 10